NABP2 and cancer: To assess whether conditional Ssb1 deletion would lead to increased cancer susceptibility, we monitored tumour development in age- and gender-matched long-term survival cohorts of Rosa26-CreERT2: Ssb1+/− (n = 35) and Rosa26-CreERT2: Ssb1−/− (n = 35) mice.